Literature DB >> 29671896

Subgroups from regression trees with adjustment for prognostic effects and postselection inference.

Wei-Yin Loh1, Michael Man2, Shuaicheng Wang3.   

Abstract

Identification of subgroups with differential treatment effects in randomized trials is attracting much attention. Many methods use regression tree algorithms. This article addresses 2 important questions arising from the subgroups: how to ensure that treatment effects in subgroups are not confounded with effects of prognostic variables and how to determine the statistical significance of treatment effects in the subgroups. We address the first question by selectively including linear prognostic effects in the subgroups in a regression tree model. The second question is more difficult because it falls within the subject of postselection inference. We use a bootstrap technique to calibrate normal-theory t intervals so that their expected coverage probability, averaged over all the subgroups in a fitted model, approximates the desired confidence level. It can also provide simultaneous confidence intervals for all subgroups. The first solution is implemented in the GUIDE algorithm and is applicable to data with missing covariate values, 2 or more treatment arms, and outcomes subject to right censoring. Bootstrap calibration is applicable to any subgroup identification method; it is not restricted to regression tree models. Two real examples are used for illustration: a diabetes trial where the outcomes are completely observed but some covariate values are missing and a breast cancer trial where the outcome is right censored.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  bootstrap; differential treatment effect; missing value; precision medicine

Mesh:

Year:  2018        PMID: 29671896      PMCID: PMC7015042          DOI: 10.1002/sim.7677

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  19 in total

Review 1.  Credibility of claims of subgroup effects in randomised controlled trials: systematic review.

Authors:  Xin Sun; Matthias Briel; Jason W Busse; John J You; Elie A Akl; Filip Mejza; Malgorzata M Bala; Dirk Bassler; Dominik Mertz; Natalia Diaz-Granados; Per Olav Vandvik; German Malaga; Sadeesh K Srinathan; Philipp Dahm; Bradley C Johnston; Pablo Alonso-Coello; Basil Hassouneh; Stephen D Walter; Diane Heels-Ansdell; Neera Bhatnagar; Douglas G Altman; Gordon H Guyatt
Journal:  BMJ       Date:  2012-03-15

Review 2.  An overview of statistical planning to address subgroups in confirmatory clinical trials.

Authors:  Gary G Koch; Todd A Schwartz
Journal:  J Biopharm Stat       Date:  2014       Impact factor: 1.051

Review 3.  A Bayesian approach to subgroup identification.

Authors:  James O Berger; Xiaojing Wang; Lei Shen
Journal:  J Biopharm Stat       Date:  2014       Impact factor: 1.051

Review 4.  Strategies for identifying predictive biomarkers and subgroups with enhanced treatment effect in clinical trials using SIDES.

Authors:  Ilya Lipkovich; Alex Dmitrienko
Journal:  J Biopharm Stat       Date:  2014       Impact factor: 1.051

5.  Subgroup identification from randomized clinical trial data.

Authors:  Jared C Foster; Jeremy M G Taylor; Stephen J Ruberg
Journal:  Stat Med       Date:  2011-08-04       Impact factor: 2.373

6.  How to work with a subgroup analysis.

Authors:  Bernadette Dijkman; Bauke Kooistra; Mohit Bhandari
Journal:  Can J Surg       Date:  2009-12       Impact factor: 2.089

7.  Subgroup identification based on differential effect search--a recursive partitioning method for establishing response to treatment in patient subpopulations.

Authors:  Ilya Lipkovich; Alex Dmitrienko; Jonathan Denne; Gregory Enas
Journal:  Stat Med       Date:  2011-07-22       Impact factor: 2.373

8.  The Challenges of Generating Evidence to Support Precision Medicine.

Authors:  Mark J Pletcher; Charles E McCulloch
Journal:  JAMA Intern Med       Date:  2017-04-01       Impact factor: 21.873

Review 9.  Multiplicity considerations in subgroup analysis.

Authors:  Alex Dmitrienko; Brian Millen; Ilya Lipkovich
Journal:  Stat Med       Date:  2017-08-01       Impact factor: 2.373

10.  Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. German Breast Cancer Study Group.

Authors:  M Schumacher; G Bastert; H Bojar; K Hübner; M Olschewski; W Sauerbrei; C Schmoor; C Beyerle; R L Neumann; H F Rauschecker
Journal:  J Clin Oncol       Date:  1994-10       Impact factor: 44.544

View more
  1 in total

1.  Predictive modeling of COPD exacerbation rates using baseline risk factors.

Authors:  Dave Singh; John R Hurst; Fernando J Martinez; Klaus F Rabe; Mona Bafadhel; Martin Jenkins; Domingo Salazar; Paul Dorinsky; Patrick Darken
Journal:  Ther Adv Respir Dis       Date:  2022 Jan-Dec       Impact factor: 5.158

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.